32 results on '"Heneine, Walid"'
Search Results
2. A mAb for the detection of the antiretroviral drug emtricitabine.
3. The predictive value of macaque models of preexposure prophylaxis for HIV prevention.
4. Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques.
5. Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
6. Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
7. HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.
8. Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.
9. HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate.
10. Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups.
11. Nondaily preexposure prophylaxis for HIV prevention.
12. Cabotegravir long-acting for HIV-1 prevention.
13. Depot-Medroxyprogesterone Acetate Does Not Reduce the Prophylactic Efficacy of Emtricitabine and Tenofovir Disoproxil Fumarate in Macaques.
14. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
15. Animal models of antiretroviral prophylaxis for HIV prevention.
16. Delayed Maturation of Antibody Avidity but Not Seroconversion in Rhesus Macaques Infected With Simian HIV During Oral Pre-Exposure Prophylaxis.
17. High Susceptibility to Repeated, Low-Dose, Vaginal SHIV Exposure Late in the Luteal Phase of the Menstrual Cycle of Pigtail Macaques.
18. Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral Therapy.
19. LACK OF CROSS-SPECIES TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUS INFECTION TO NONHUMAN PRIMATE RECIPIENTS OF PORCINE CELLS, TISSUES, OR ORGANS1.
20. Viral load differences in early infection with two HIV-1 subtypes.
21. DEVELOPMENT AND VALIDATION OF A WESTERN IMMUNOBLOT ASSAY FOR DETECTION OF ANTIBODIES TO PORCINE ENDOGENOUS RETROVIRUS1.
22. The phylogeny and molecular epidemiology of human T-cell lymphotropic virus type II.
23. HIGHLY SENSITIVE AND SPECIFIC POLYMERASE CHAIN REACTION ASSAYS FOR DETECTION OF BABOON AND PIG CELLS FOLLOWING XENOTRANSPLANTATION IN HUMANS.
24. Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro.
25. HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis.
26. Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups.
27. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.
28. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
29. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
30. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.
31. HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.
32. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.